|Articles|January 30, 2013

Amid Flu Epidemic a Focus on Vaccine Innovation

Author(s)RPaul

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!

Related Content

Maintaining a Strong Company Culture Through Difficult Times

BySocietal CDMO

January 8th 2024

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

Congress Leaves Town with Major Drug-Related Bills on Hold

ByJill Wechsler

July 28th 2023

Large Clinical Trial Supports Alzheimer Drug Full Approval

ByJill Wechsler

July 11th 2023

Long-Admired PEPFAR Program Caught in Abortion Debate

ByJill Wechsler

June 16th 2023

Medicare Still Won’t Pay for Alzheimer’s Drugs without Confirmatory Data

ByJill Wechsler

June 5th 2023

Amid Flu Epidemic a Focus on Vaccine Innovation

Newsletter

Related Content

Maintaining a Strong Company Culture Through Difficult Times

Congress Leaves Town with Major Drug-Related Bills on Hold

Large Clinical Trial Supports Alzheimer Drug Full Approval

Long-Admired PEPFAR Program Caught in Abortion Debate

Medicare Still Won’t Pay for Alzheimer’s Drugs without Confirmatory Data

Trending on Pharmaceutical Technology

Kimberly-Clark to Buy Tylenol Maker Kenvue: Analyzing Risks and Rewards

How the Critical Medicines Act Aims to Optimize European Pharma Competitiveness and Resilience